Vanguard Group’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-395,626
| Closed | -$1.17M | – | 4167 |
|
|
2019
Q3 | $1.17M | Buy |
395,626
+1,170
| +0.3% | +$2.4K | ﹤0.01% | 3609 |
|
|
2019
Q2 | $749K | Buy |
394,456
+230,522
| +141% | +$472K | ﹤0.01% | 3748 |
|
|
2019
Q1 | $316K | Buy |
163,934
+26,605
| +19% | +$53K | ﹤0.01% | 3841 |
|
|
2018
Q4 | $206K | Buy |
137,329
+11,935
| +10% | +$23.9K | ﹤0.01% | 3895 |
|
|
2018
Q3 | $296K | Buy |
125,394
+1,403
| +1% | +$3.03K | ﹤0.01% | 3941 |
|
|
2018
Q2 | $335K | Buy |
123,991
+49,262
| +66% | +$143K | ﹤0.01% | 3900 |
|
|
2018
Q1 | $220K | Buy |
74,729
+21,273
| +40% | +$69.7K | ﹤0.01% | 3942 |
|
|
2017
Q4 | $174K | Sell |
53,456
-12,259
| -19% | -$107K | ﹤0.01% | 3948 |
|
|
2017
Q3 | $1.01M | Sell |
65,715
-3,600
| -5% | -$58.2K | ﹤0.01% | 3590 |
|
|
2017
Q2 | $1.39M | Sell |
69,315
-9,538
| -12% | -$118K | ﹤0.01% | 3495 |
|
|
2017
Q1 | $788K | Buy |
78,853
+636
| +0.8% | +$7.06K | ﹤0.01% | 3642 |
|
|
2016
Q4 | $739K | Sell |
78,217
-9,237
| -11% | -$99.1K | ﹤0.01% | 3648 |
|
|
2016
Q3 | $945K | Buy |
87,454
+994
| +1% | +$14.7K | ﹤0.01% | 3589 |
|
|
2016
Q2 | $1.49M | Sell |
86,460
-4,244
| -5% | -$132K | ﹤0.01% | 3478 |
|
|
2016
Q1 | $3.4M | Buy |
90,704
+34,040
| +60% | +$1.36M | ﹤0.01% | 3153 |
|
|
2015
Q4 | $3.87M | Buy |
56,664
+2,094
| +4% | +$150K | ﹤0.01% | 3103 |
|
|
2015
Q3 | $3.15M | Buy |
54,570
+11,678
| +27% | +$1.03M | ﹤0.01% | 3172 |
|
|
2015
Q2 | $3.39M | Buy |
42,892
+3,661
| +9% | +$246K | ﹤0.01% | 3188 |
|
|
2015
Q1 | $2.65M | Buy |
39,231
+3,030
| +8% | +$195K | ﹤0.01% | 3290 |
|
|
2014
Q4 | $1.39M | Sell |
36,201
-930
| -3% | -$37.6K | ﹤0.01% | 3415 |
|
|
2014
Q3 | $1.61M | Buy |
37,131
+621
| +2% | +$29.1K | ﹤0.01% | 3351 |
|
|
2014
Q2 | $2.19M | Buy |
36,510
+2,023
| +6% | +$113K | ﹤0.01% | 3227 |
|
|
2014
Q1 | $2.71M | Buy |
34,487
+7,938
| +30% | +$615K | ﹤0.01% | 3090 |
|
|
2013
Q4 | $1.62M | Buy |
26,549
+748
| +3% | +$43.5K | ﹤0.01% | 3273 |
|
|
2013
Q3 | $1.7M | Buy |
25,801
+24,120
| +1,435% | +$1.95M | ﹤0.01% | 3198 |
|
|
2013
Q2 | $154K | Buy |
+1,681
| New | +$139K | ﹤0.01% | 3675 |
|
Vanguard Group's FCSC Position: Q4 2019 in Review
Vanguard Group sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 395,626 shares — an estimated $1.17M sold.
Vanguard Group first reported a position in FCSC in Q2 2013 and held it in 26 quarters. The position peaked at $3.87M in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Vanguard Group reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Vanguard Group sold 395,626 Fibrocell Science Inc. shares in Q4 2019, an estimated $1.17M.
- Vanguard Group first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 26 quarters.
- Vanguard Group's Fibrocell Science Inc. position peaked at $3.87M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.